- The dental workforce trends that will dominate 2026
- Federal Medicaid cuts threaten dental care access: See the potential impact by state
- Children’s Mercy raises $150M for mental healthcare
- California awards $291M to expand behavioral health housing, services
- Think bigger – Turning AI from Trends to Long-Term Transformation
- UnityPoint Health hospital names market chief nursing officer
- OhioHealth builds well-being programs to reshape caregiver culture
- Washington hospital staff vote ‘no confidence’ in management company
- U of Mississippi Medical Center restores phone lines after cyberattack
- 13 health system IT leadership moves
- How health systems are repositioning informatics
- Mississippi hospital names COO
- Ex-Amazon Health leader joins Spotify founder’s health tech startup
- Know the True Value of Your Lab When an Offer Is on the Table
- U of California offers 32% wage hike in union talks
- UF Health taps new outpatient senior VP
- UAMS names new director of cardiovascular medicine division
- CMS’ add-on billing code boosts specialist pay: Study
- Lawmakers introduce bill to reverse Medicaid cuts, expand Medicare benefits
- Florida medical center to expand with ASC
- New Jersey woman charged with practicing unlicensed dentistry
- CMS extends hospital-at-home waivers for 5 years: What ASCs need to know
- 100+ organizations call on CMS to revise 2027 MA rates
- The retention breakthrough anesthesia needs
- Oklahoma advances interstate compact bill
- Brown University Health names new chief of cardiac surgery
- UNC Health Appalachian offers psychiatric physician training program
- Former PepperPointe Partnerships COO joins DPO
- The Smilist expands into Virginia
- Physician-led orthopedic ASC opens in Florida
- Colorado Medicaid ABA audit finds $77.8M in improper payments
- Georgia opens 30-bed forensic mental health unit to ease jail backlog
- Pennsylvania county cuts ribbon on $19.8M mental health diversion center
- Outpatient cardiology’s CMS whiplash
- 12 new ASCs in February
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- UHS to roll out behavioral health revenue cycle AI tools in 2026
- 15 dentists making headlines
- CMS to suspend enrollment into Elevance’s Medicare Advantage plans
- Report: Most states investing in value-based care with Rural Health Transformation Program
- U.S. Tops 1,100 Measles Cases This Year as Outbreaks Grow
- FDA To Offer Cash Bonuses for Faster Drug Reviews
- 10 providers seeking RCM talent
- PDS Health added de novos across 3 states in February
- Novant posts 4.8% operating margin in 2025
- 'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing
- Cleveland Clinic posts $913M operating income, 5% margin — 7 things to know
- Former Optum CEO Heather Cianfrocco to depart UnitedHealth Group
- New Drug, Acoziborole, Could Boost Efforts to Wipe Out Sleeping Sickness
- Chocolate Male Supplement Recalled Over Hidden Erectile Dysfunction Drug
- Clinician Engagement: The Operating Lever Behind Margin and Throughput
- Your Anesthesia Subsidy: Key Questions Every Hospital C-Suite Must Answer
- Amid unfolding Middle East war, pharma giants keep close eye on employee safety, supply chains
- CMS set to suspend enrollment in Elevance Health's Medicare Advantage plans
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Kennedy adds 2 new members to CDC’s vaccine panel ahead of delayed meeting
- Urban Traffic Noise Disrupts Sleep, Affects Heart Health After One Night
- Hormone Therapy Might Be Unnecessary For Some Prostate Cancer Patients
- Benzodiazepine Use Down In U.S., But OD Risk Remains, Study Says
- GLP-1 Drugs Might Ease Chronic Migraine, Study Says
- Blood Test Reveals Alcohol-Related Liver Disease
- Telemedicine Visits Cost Five Times Less Than In-Clinic Care
- Families Defend Disability Services Amid Medicaid Cuts
- Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
- Bavarian Nordic CEO to follow board chair out the door after failed private equity takeover
- Ascendis gains more altitude with FDA approval for dwarfism drug Yuviwel
- CDMO Quotient extends Ipsen supply pact for rare disease drug Sohonos
- Quest Diagnostics launches Google-powered AI chatbot to help patients understand lab results
- Tennr takes aim at phone call bottlenecks as it builds out automation for patient referral process
- DoseSpot, Arrive Health merge to combine prescribing tools with pharmacy, medical benefit data
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Why Digital Tool are Needed to Cope with Increasing Pressures in MedTech Innovation
- Electronics Pollution Pose Added Threat to Endangered Dolphins, Porpoises
- Flea And Tick Pills May Pose Environmental Risks, Study Finds
- ICE, ALS, Addiction Medicine, and Robotic Ultrasounds: Journalists Sound Off on All That and More
- 11 behavioral health executive moves to know
- 3 behavioral healthcare M&A deals in 2026
- Anthem Blue Cross of California pushes E/M downcoding policy to April
- Iowa dentist surrenders license
- Temple University gets approval for $3.19M rural dental clinic
- A Canadian Hospital Scoops Up Nurses Who No Longer Feel Safe in Trump’s America
- Statement on the Adoption of Final Rules Under the Holding Foreign Insiders Accountable Act
- Statement on Final Rules for the Holding Foreign Insiders Accountable Act
- State Medicaid budgets to weather $664B reduction through 2034 due to OBBBA: RAND
- Clover Health CEO said company sees opportunity in complex MA environment
- How pharma marketers are capturing the power of podcasts to connect with consumers
- Cigna's Evernorth quietly acquires hospital pharmacy CarepathRx
- Walgreens debuts virtual weight management clinic with access to GLP-1 meds
- New Obamacare Rules Could Raise Deductibles to $31K For Families
- Study Suggests One Common Amino Acid May Affect How Long Men Live
- Merck to wind down Gardasil production at N.C. plant, lay off 150-plus
- Walmart Great Value Cottage Cheese Recalled Over Pasteurization Issue
- Chris Bosh Says He’s 'Lucky To Be Alive' After Sudden Health Scare
- Patrick Kennedy: Collab with MAHA is essential to address mental health crisis
- Lilly debuts Nvidia supercomputer with fanfare and focus on escaping traditional pharma lifecycle
- Alignment CEO John Kao offers measured response to proposed 2027 MA rates
- Sanofi, Genentech, Kedrion back star-studded bleeding disorder awareness campaign
- Op-ed: Our patients deserve better safety reporting. AI could be the answer
- After CHMP nod, Moderna CEO applauds EU's 'rigorous scientific review'
- UCB's fast-growing Bimzelx leaps across blockbuster sales threshold as HS momentum builds
- How the Brain Learns to Have Seizures During Sleep
- Blood Test Can Predict Short-Term Survival Among Seniors
- Why Turning 19 Spikes Medicaid Loss for Millions
- Crash Course Might Speed Brain Stimulation Treatment For Depression, Study Suggests
- Wildfire Smoke Linked To Increase In Violent Assaults
- More Parents Are Refusing A Life-Saving Shot For Their Newborns, Study Finds
- He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
- To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
- As SCOTUS takes on 'skinny label' review, top US lawyer sides with generics maker
- Lake Nona Impact Forum: There can't be longevity without tech
- Fierce Pharma Asia—China deal growth; Daiichi's new CMO; Astellas-Vir bispecific tie-up
- Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- FDA Approval for BIOTRONIK Solia CSP S Pacing Lead For LBBAP
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Catalyst OrthoScience gets FDA 510(k) Clearance of Archer® Patient-Specific Instrumentation for Shoulder Arthroplasty
- Smith+Nephew signs distribution agreement with SI-BONE
- Smith+Nephew signs distribution agreement with SI-BONE
- Quantum Surgical Acquires NeuWave Medical, Inc.
- Quantum Surgical Acquires NeuWave Medical, Inc.
- How Pharma is Expanding its Global Footprint to Advance Clinical Research
- Partnering to Advance Drug Delivery Innovation
- What the Health? From KFF Health News: What About the State of Health?
- Teladoc Health reports slower growth, offers cautious 2026 outlook as it shifts telehealth model
- CFO Mark Kaye to take the helm at Carelon in leadership shake-up at Elevance Health
- Insurance groups say proposed flat Medicare Advantage rates fail to meet the moment
- Health Gorilla urges court to toss lawsuit filed by Epic, health systems
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Stryker launches Synchfix™ EVT, expanding options for flexible syndesmotic fixation
- Democrat-Led States Sue Trump Administration Over Cuts to Childhood Vaccine Schedule
- CDC Vaccine Advisory Panel To Revisit COVID Shot Safety Next Month
- Frozen Blueberry Recall Issued Across Four States for Listeria
- Boehringer's Hernexeos secures speedy first-line expansion in FDA's 2nd national priority nod
- 'Like talking to a brick wall': Senate hearing takes aim at FDA's rare disease review process
- After delay, CDC vaccine panel sets new dates to discuss long COVID and mRNA shot safety
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Decision Criteria for Technology Commercialization of Medical Devices in 2026
- Cientos de enfermeros estadounidenses dejan atrás el Estados Unidos de Trump y eligen trabajar en Canadá
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Continuous Cardiac Monitoring: Redefining the “End” of a Clinical Study?
- Could Drone-Delivered Defibrillators Save Lives?
- Inflammation Linked To Brain Damage, Memory Problems Among Football Players
- Early Birds, Active Folks Less Likely To Develop ALS
- Disasters Can Affect Mental Health A Decade Later, Review Finds
- AI Chatbots Can Contribute To Worsening Mental Illness, Study Finds
- Newborns Exposed to More ‘Forever Chemicals’ Than Once Thought
- Study Highlights Unique Parenting Struggles of Younger Patients With Heart Disease
- Altman-backed startup Verifiable rolls out AI agent to automate credentialing
- ‘You Aren’t Trapped’: Hundreds of US Nurses Choose Canada Over Trump’s America
- ‘Kind of Morbid’: Health Premiums Threaten Their Nest Egg. A Terminal Diagnosis May Spare It.
National Institutes of Health (NIH) Director Jay Bhattacharya was on the receiving end of a diversity, equity and inclusion (DEI) firestorm during the COVID panic. He firmly believes the scientific approach to turn discoveries into better health has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI).
Here is his action plan:
https://thespectator.com/topic/cured-dei-national-institutes-health-jay-bhattacharya-matthew-memoli/
How we cured DEI at the National Institutes of Health
Scientists no longer have to mouth DEI shibboleths to garner funding
By Jay Bhattacharya and Matthew J. Memoli - December 11, 2025Since the National Institutes of Health was founded as a one room laboratory in 1887 its mission was simple; perform biomedical research to enhance health, lengthen life and reduce illness and disability for Americans. Scientists for more than one hundred years have taken this scientific approach to turn discoveries into better health. This mission unites all Americans of every race, color and creed. Everyone wants science that benefits their health.
Over the last decade and a half this mission has been corrupted by a new mission and ideology: diversity, equity and inclusion (DEI). This political ideology was reflected in all aspects of the NIH, including hiring practices, promotion and tenure, employee training, performance reviews, communications, management and, yes, even science.
For its entire history NIH funding decisions were made to reach scientific goals. DEI drove decisions to be made to reach political goals instead, requiring NIH scientists to write DEI statements – de facto loyalty oaths – and researchers outside the NIH applying for grants to write plans for enhancing “diverse perspectives” (another name for a DEI statement). Scientific reviewers were chosen based on DEI criteria, and those making funding decisions received bonuses for promoting DEI.
At the end of every fiscal year, NIH program officers handed out “diversity supplements” to universities, directing money to training programs based partly on scientists’ race, rather than their scientific ability. In 2022, the NIH announced funding for universities to conduct “system-wide” DEI audits to address “shortcomings” in addressing “structural racism.”
Scientists learned that the best way to maximize their chance of a slice of NIH money was to promise that their work would help achieve racial nirvana, however remote from utopian ideological pursuits the proposed work actually was. Most scientists obsequiously complied to avoid the risk of career harm, whether they were true believers or not.
NIH policy was fundamental in the DEI-ification of the nation’s top universities and research centers. Even before the fevered days of 2020, when the mania for DEI at universities reached a fever pitch, scientists were often required to write DEI loyalty oaths to be hired or promoted.
In 2020, at Stanford University, radical students circulated a blacklist of professors they considered guilty of wrongthink and harassed them for their ideological impurity. The administration published an “elimination of harmful language” banned word list, creating a hostile work environment for those whose beliefs fell outside the bounds of orthodox DEI-ism. All of this occurred with the approval and even applause of university leaders. Stanford was not alone; top universities embraced similar policies.
None of this reorientation of the NIH and the universities toward DEI translated into improving the health status of Americans. Between 2011 and 2019, life expectancies of nearly every racial group in the US flatlined. All Americans shared in the expanding chronic disease crisis that has made America among the least healthy economically developed nations on earth. Chronic disease does not discriminate and DEI is not the solution.
NIH’s devotion to DEI ended when President Trump took office in January 2025. At the NIH, we dismantled the DEI apparatus and refocused the NIH on its age-old mission. We oversaw a large-scale effort by all parts of NIH to eliminate DEI from its processes, including eliminating loyalty oaths and other DEI statements, removing DEI from performance reviews, hiring and promotion, and purging DEI from all facets of scientific review, notices of funding opportunity (NOFO) and grant decision making.
Though activist courts have restricted our ability to excise many DEI-focused grants from our portfolio, NIH has now terminated hundreds of NOFOs and modified the terms of more than 6,000 grants that contain unscientific DEI-related statements, projects and methods. Because DEI was so deeply embedded in the NIH’s portfolio, it will take some time to complete the work, but by the end of this fiscal year, we will have restored merit and science-based research to their rightful place at the NIH.
We continue to enthusiastically support research that advances the health of all Americans, regardless of their age, race, ethnicity, sex, sexual orientation, or other characteristics. We will unapologetically invest in rigorous science – research that genuinely improves the health of minority populations, rather than serving political ideologies that misuse taxpayer resources.
The NIH will not fund research based on ideologies that promote differential treatment of people based on race or ethnicity, nor will we fund studies exploring broad, poorly defined concepts such as racial microaggressions or implicit bias. Such work diverts resources away from projects that advance the health and longevity of all Americans, including minority populations.
So that the NIH never again strays from its mission, we have established new formal priorities for the NIH, with DEI removed and gold standard science leading the way. Scientists will no longer have to mouth DEI shibboleths to garner funding but instead propose excellent science that helps make America healthy again.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















